Top Institutions in Ophthalmology - Diabetic Retinopathy and Retinal Disease
Leading institutions in this field conduct extensive clinical trials, translational research, and drug development focused on retinal diseases, diabetic retinopathy, and novel intravitreal therapies. They often collaborate with pharmaceutical companies and lead multicenter phase 2 and phase 3 clinical trials to evaluate efficacy and safety of emerging treatments like EYP-1901.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and clinical trials, with extensive expertise in diabetic retinopathy and novel intravitreal therapies. They have a strong track record of leading pivotal studies and developing innovative treatments for retinal vascular diseases.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is internationally recognized for its clinical and translational research in diabetic retinopathy and retinal vascular diseases. It has a robust clinical trials program evaluating novel drug delivery systems and anti-VEGF agents.
-
#3
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital has a long-standing reputation for excellence in retinal disease management and research, including diabetic retinopathy. It actively participates in clinical trials for new therapies targeting VEGF and other pathways in retinal vascular diseases.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in ophthalmic research and clinical trials, with significant contributions to understanding diabetic retinopathy pathophysiology and treatment. They have expertise in evaluating novel drug delivery systems and anti-angiogenic therapies.